Bimatoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. The DMF is on file with the US FDA, Canada, and in several EU member states.
Cayman Pharma. s r.o.
ul. Práce 657 · 277 11 Neratovice
Autorské právo 2019 Cayman Pharma